Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension

This study has been completed.

Study NCT00326768 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: May 16, 2006 Last Updated: November 25, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2007
Estimated Primary Completion Date:	No date given